Clinical Trial: Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Erythrocyte-Mediated Drug Delivery for the Prevention of Restenosis After Coronary Artery Stent Implantation:TROY-Study

Brief Summary: The purpose of this study is to determine whether erythrocyte mediated dexamethasone delivery reduces circulating inflammatory markers after coronary stent implantation and improves clinical and angiographic outcomes.